Full Version | Search

The Irish Medicines Board - www.imb.ie

IMB Logo

Click here for the RSS feed for Publications IMB Publications RSS Feed

Publications

Below you will find a list of all IMB Publications. You can filter this list by choosing from the tags on the left and you can select multiple tags if you wish. Before commencing a new search, please ensure you remove any tags/filters you have previously applied by clicking Remove Filters.

You can also search all Publications by entering a keyword(s) in the search box and clicking the Search link.

Search:  Search

Page 2 of 24
Date Title
28/02/2013 Drug Safety Newsletter 52nd Edition
28/02/2013 Guide to hospital-based advanced therapy medicinal products
26/02/2013 IMB Newsletter Issue No. 43 Sept - Dec 2012
26/02/2013 NeuroBloc (Botulinum Toxin Type B) Important Safety Information from Eisai Ltd as approved by the Irish Medicines Board
21/02/2013 Prolia (denosumab) Important Safety Information from Amgen Ireland Limited as approved by the Irish Medicines Board
04/02/2013 Xagrid (anagrelide hydrochloride) - Important Safety Information from Shire as approved by the Irish Medicines Board
01/02/2013 Field Safety Notice Monthly Summary Sheet - January 2013
24/01/2013 Tredaptive (nicotinic acid/laropiprant) - Important Safety Information from Merck Sharp & Dohme as approved by the Irish Medicines Board
17/01/2013 Tisseel Lyo, Tisseel Ready to use and Artiss Solutions for Sealant (Human Fibrinogen) - Important Safety Information from Baxter as approved by the Irish Medicines Board
15/01/2013 Clinical Trial Subcommittee Meeting Dates and Application Cut-off Dates for 2013
14/01/2013 Gilenya (fingolimod) - Important Safety Information from Novartis Ireland Ltd as approved by the Irish Medicines Board
14/01/2013 Guide to Clinical Trial Applications
11/01/2013 Tredaptive (nicotinic acid/laropiprant) - Important Safety Information from Irish Medicines Board
09/01/2013 Revlimid (lenalidomide) - Important Safety Information from Celgene as approved by the Irish Medicines Board
08/01/2013 Tredaptive (nicotinic acid/laropiprant) - Important Safety Information from Merck Sharp & Dohme as approved by the Irish Medicines Board
08/01/2013 Regulatory Affairs Contact Information
08/01/2013 Pradaxa (dabigatran etexilate) - Important Safety Information from Boehringer Ingelheim as approved by the Irish Medicines Board
07/01/2013 Paracetamol Overdose: New Guidance on Treatment with Intravenous Acetylcysteine
04/01/2013 Angiox (bivalirudin) - Important Safety Information from The Medicines Company as approved by the Irish Medicines Board
04/01/2013 Regulatory requirements for the procurement, in the Republic of Ireland, of Human Tissues and Cells intended for human application
Page 2 of 24



Date Printed: 26 May 2013

© Irish Medicines Board 2013 | Developed by Engine Solutions www.engine.ie

Address: Kevin O'Malley House, Earlsfort Centre, Earlsfort Terrace, Dublin 2, Ireland.
Tel: 353-1-676 4971